Country: U.S.A.

Industry: Biotechnology

Year: 2021

Service(s): 16

Detailed: [CASE STUDY]

1910 Genetics is building two AI-driven computational platforms, ROSALYND and ELVIS, designed to accelerate the design of both small molecule drugs and protein therapeutics. Their goal is to identify novel molecules within existing biological systems with therapeutic potential.

Drawing on their expertise in molecular biology and complex systems, 1910 Genetics take a biology-first approach to target molecule identification and selection. They leverage computational platforms encompassing AI, big data, and structural biology to rapidly discover potential pharmaceutical drug molecules, aiming to address diseases previously deemed incurable and undruggable.

Since 1910 Genetics’ computational models are quite novel in their field of application, the visual vocabulary we needed to express their functionality and impact practically didn’t exist.

With this in mind, our first challenge was building this visual vocabulary to serve as an accurate expression of AI and machine learning.

However, our biggest challenge was further refining this visual vocabulary to express what 1910 Genetics refers to as “solving the human problem.” In layman’s terms, this meant discovering new pharmaceuticals to cure diseases by solving a computational problem, but using molecular biology as the basis of their approach.

Craft 1910’s story into a warm, elegant visual narrative that steps away from the neutral aesthetic of the pharmaceutical and biotech industry; setting a new course for visual expression in this area of AI and machine learning implementation.

In other words: add a human touch to the story of solving the human problem.

Complete a brand refresh of 1910 Genetics, rebranding them into a premium biotech company while keeping a few core elements.

Create a full suite of stylized, but accurate, 3D/2D visual assets — static, motion, and video — for their two bio-computing platforms.

Coordinate with 1910 Genetics’ in-house team and their contracted PR agency to establish messaging around the visual content.

Craft an aesthetic that compliments the technology and resonates with the message through a tone of soft-spoken elegance.

Create a web experience that will immediately distinguish 1910 Genetics from their competition by showcasing their sophisticated approach.

Provide 1910 Genetics with a full suite of additional assets help to secure funding and establish partnerships with pharmaceutical companies.

$26.7M Series A and Seed funding

9 to 38 Company/employee growth

Open 1st State-of-the-art laboratory